                               SEQUENCE LISTING	

<110> ADURO BIOTECH
 
<120> METHODS AND COMPOSITIONS USING LISTERIA FOR ADJUVANT TREATMENT OF 
      CANCER

<130> ANZ-2200-PC2

<140> PCT/US2011/037602
<141> 2011-05-23

<150> 61/347,447
<151> 2010-05-23

<160> 5     

<170> PatentIn version 3.5

<210> 1
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Ser Ile Ile Asn Phe Glu Lys Leu 
1               5               


<210> 2
<211> 12
<212> PRT
<213> Mus musculus

<400> 2
Glu Glu Asp Lys Ser Pro Val Arg Asp Trp Leu Phe 
1               5                   10          


<210> 3
<211> 12
<212> PRT
<213> Mus musculus

<400> 3
Asp Lys Ser Pro Val Arg Asp Trp Leu Phe Arg Gln 
1               5                   10          


<210> 4
<211> 12
<212> PRT
<213> Mus musculus

<400> 4
Ser Pro Val Arg Asp Trp Leu Phe Arg Gln His Gln 
1               5                   10          


<210> 5
<211> 9
<212> PRT
<213> Homo sapiens

<400> 5
Ser Gly Pro Gln Ala Cys Thr Arg Phe 
1               5 
          


